CME Group Inc. (NASDAQ:CME) Given Consensus Rating of “Hold” by Brokerages

CME Group Inc. (NASDAQ:CMEGet Free Report) has earned a consensus recommendation of “Hold” from the ten research firms that are covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $217.30.

A number of equities analysts have weighed in on CME shares. Rosenblatt Securities restated a “sell” rating and issued a $180.00 target price on shares of CME Group in a research note on Thursday, January 4th. Argus raised their price target on CME Group from $225.00 to $245.00 and gave the stock a “buy” rating in a research report on Wednesday, March 6th. The Goldman Sachs Group lowered CME Group from a “neutral” rating to a “sell” rating and set a $195.00 price target on the stock. in a research report on Wednesday, January 3rd. Finally, Barclays raised their price target on CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 15th.

Get Our Latest Report on CME

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Norges Bank bought a new stake in shares of CME Group in the fourth quarter worth $959,260,000. Capital Wealth Planning LLC bought a new stake in shares of CME Group in the fourth quarter worth $253,563,000. Capital World Investors lifted its position in CME Group by 8.7% during the fourth quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock valued at $3,072,654,000 after purchasing an additional 1,172,575 shares in the last quarter. Morgan Stanley lifted its position in CME Group by 31.5% during the third quarter. Morgan Stanley now owns 4,858,967 shares of the financial services provider’s stock valued at $972,863,000 after purchasing an additional 1,163,103 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its position in shares of CME Group by 40.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 3,615,243 shares of the financial services provider’s stock valued at $761,371,000 after acquiring an additional 1,048,511 shares in the last quarter. Institutional investors own 85.69% of the company’s stock.

CME Group Stock Performance

Shares of CME opened at $216.36 on Wednesday. The stock’s 50-day simple moving average is $210.21 and its 200 day simple moving average is $210.45. The stock has a market capitalization of $77.89 billion, a price-to-earnings ratio of 24.39, a price-to-earnings-growth ratio of 3.43 and a beta of 0.49. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group has a 52-week low of $175.73 and a 52-week high of $223.80.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings data on Wednesday, February 14th. The financial services provider reported $2.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.10. The business had revenue of $1.44 billion for the quarter, compared to analysts’ expectations of $1.43 billion. CME Group had a return on equity of 12.32% and a net margin of 57.83%. The firm’s quarterly revenue was up 19.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.92 EPS. Research analysts forecast that CME Group will post 9.63 EPS for the current fiscal year.

CME Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 26th. Stockholders of record on Friday, March 8th will be paid a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.13%. The ex-dividend date of this dividend is Thursday, March 7th. This is a boost from CME Group’s previous quarterly dividend of $1.10. CME Group’s dividend payout ratio (DPR) is presently 51.86%.

About CME Group

(Get Free Report

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.